SEC Form 4 · accession 0001179110-17-002964
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew H Lane
Officer — Senior Vice President
Period of report
Feb 17, 2017
Accepted (ET)
Feb 22, 2017 · 6:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 20, 2017 | F | 605 | $44.69 | D | 15,176 | D | |
| Common shares without par valueF1 | holding | — | — | — | 602 | I | Profit Sharing Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F2 | $44.40 | Feb 17, 2017 | A | 112,484 | A | Feb 17, 2018 | Feb 16, 2027 | Common shares | 112,484 | 112,484 | D |
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2017.
- F2Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 37,495 on 02/17/2018, 37,494 on 02/17/2019, and 37,495 on 02/17/2020.